medistus.com Open in urlscan Pro
92.118.24.184  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * 

 * Facebook

 * English English en
 * Magyar Hungarian hu

 * Medistus® Antivirus
 * Products
 * Infection prevention
 * Professional information
   * For consumers
   * For medicals
 * Marketing
 * About us
   * Introduction
   * Exhibitions
   * Medistus® Antivirus in the world
 * Contact
 * Menu Menu


For the prevention of infectious and inflammatory
     respiratory diseases of viral and bacterial origin by
     physical (mechanical) barrier formation on the oral
     and pharyngeal mucosa
Efficacy supported by various studies
MORE INFORMATION

IN VITRO STUDIES


For the prevention of infectious and inflammatory
       respiratory diseases of viral and bacterial origin
       by physical (mechanical) barrier formation on the
       oral and pharyngeal mucosa.
Efficacy supported by various studies
MORE INFORMATION

IN VITRO STUDIES




WHY CHOOSE
MEDISTUS® ANTIVIRUS LOZENGES?




Medistus® Antivirus is a Class IIa medical device product (CE 0482) with
Kistosyn® 200 extract. The lozenges are used for the prevention of infectious
and inflammatory respiratory diseases of viral and bacterial origin by physical
(mechanical) barrier formation on the oral and pharyngeal mucosa.

The Kistosyn® 200 extract contained in Medistus® Antivirus lozenges forms
through its natural active substances a protective film over the oral and
pharyngeal mucosa. This protective barrier leads to a physical (mechanical)
protection against viruses and bacteria causing respiratory infections, which
helps prevent their penetration into body cells and their further propagation.





NATURAL HEALTH PROTECTION IN CASE OF INFECTION RISK




RECOMMENDED USE ON PLACES WITH HIGH RISK OF INFECTION


Travel
Public transportation
Education
Waiting rooms
Event
Shopping


PRODUCTS






MEDISTUS® ANTIVIRUS

Lozenges with Kistosyn® 200 extract, in fresh fruity taste


Medistus® Antivirus is a Class IIa medical device product (CE0482) with
Kistosyn® 200 extract. 
Read more



MEDISTUS® ANTIVIRUS HONEY& LEMON

Lozenges with Kistosyn® 200 extract, in honey & lemon taste


Medistus® Antivirus is a Class IIa medical device product (CE0482) with
Kistosyn® 200 extract. 
Read more


INFECTION PREVENTION




RESPIRATORY INFECTIONS
(COLDS)



A common cold is usually a virus-induced, acute infection of the upper
respiratory tract. This type of respiratory infections is among the most common
diseases in modern industrial countries. On the average adults suffer up to five
times a year a cold, pre-schoolers even eight to ten times. In most cases the
infections are caused by viruses and associated with similar symptoms:
shivering, sneezing, runny nose, cough and fatigue. Since antibiotics work only
in the treatment of bacterial infections, applying them in case of infections of
viral origin, they might remain ineffective.




INFECTION RISKS
(PANDEMICS)



Recently, infections by emerging viruses occur more frequently and they seem to
be independent of seasons. These infections manifest themselves as fever from 38
°C and with symptoms such as sore throat, runny nose, cough, muscle and joint
pains, headache and diarrhea.
Real influenza has to be dealt with separately from the other respiratory
diseases related to cold. This infection is a disease caused by various types of
influenza viruses and differs from other respiratory diseases both in its
epidemiological, clinical characteristics and also in its impacts.




PENETRATION OF VIRUSES AND BACTERIA IN THE BODY



Infections of the upper respiratory tract caused by viruses or bacteria will not
necessarily lead to illness if the immune system is capable of effective defense
against pathogens, or the pathogens are hindered at intruding the body by a
barrier.
The main goal of a virus is to safeguard its own propagation for which it
requires a host cell. To this end, it targets the cells in the oral mucosa and
attempts to dock to them. In case of a successful attachment it penetrates the
host cell membrane and reprograms it to promote its own multiplication.




ACTIVE DEFENSE
AGAINST INFECTION



The research of the last decades has unambiguously demonstrated that in case of
infection pathogens (viruses, bacteria) dock to the carbohydrate structures of
the host cell membranes through their proteins based on the so-called key-lock
principle. This process occurs in the oral and pharyngeal mucous membranes. In
the event this docking process is successful, like a key opening a lock the
pathogens penetrate the host cell and commence to multiply. The solution is
compelling: we have to impede pathogens in docking to the host cells.

Read more


MEDISTUS® ANTIVIRUS LOZENGES


 * act as a protective film
   
   
   
 * form a natural barrier
   
   
   
 * assist preventively
   
   
   


More information


PROFESSIONAL INFORMATION



WHAT TYPE OF PRODUCT ARE MEDISTUS® ANTIVIRUS LOZENGES? / INTENDED PURPOSE

Medistus® Antivirus lozenges are a Class IIa medical device product (CE 0482)
with Kistosyn® 200 extract.
For the prevention of infectious and inflammatory respiratory diseases of viral
and bacterial origin by physical (mechanical) barrier formation on the oral and
pharyngeal mucosa.
For adults, adolescents and children from 6 years old.
Without preservatives and colorants, sugar-free, gluten-free and lactose-free.

IN WHICH CASES SHALL MEDISTUS® ANTIVIRUS BE APPLIED? / AREAS OF APPLICATION

AREAS OF APPLICATION:

 * To support by physical means the natural barrier function of the oral and
   pharyngeal mucosa by forming a protective film on it.
 * For the prevention of infectious and inflammatory respiratory diseases of
   viral and bacterial origin by physical (mechanical) barrier formation on the
   oral and pharyngeal mucosa.


Read more




INTRODUCTION



The production of Medistus® Antivirus lozenges takes place according to DIN EN
ISO and GMP standards at the production site of a highly recognized
pharmaceutical manufacturer in Germany using strictly controlled natural
substances.



The license holder and the owner of the technical documentation of Medistus®
Antivirus lozenges is the Innopharm GmbH in Austria.
The main activity of the company encompasses the trading and distribution of
medical devices.
The Innopharm GmbH provides all necessary clinical studies and laboratory tests
which are essential for the safety and efficacy of its medical devices.
Furthermore, the Innopharm GmbH is the head of product development and
innovation.



The exclusive rights for worldwide distribution are conferred upon the Vitaplus
Kft in Hungary owing to its long-term experience and extensive network of
commercial partners.
Medistus® Antivirus was introduced by Vitaplus Kft in numerous countries in
Europe and has successfully been distributed there ever since.

Link to: Fertőzésmegelőzés



LEARN
MORE!



Link to: Szakmai információk


CLINICAL
AND MEDICAL
INFORMATION


Go to top
© Copyright - Medistus® Antivirus
 * Facebook

 * Impressum
 * Data protection information

Scroll to top